Correction: The Pathogenic Aβ43 Is Enriched in Familial and Sporadic Alzheimer Disease

Correction: The Pathogenic Aβ43 Is Enriched in Familial and Sporadic Alzheimer Disease

Bibliographic Details
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2013-01-01
Series:	PLoS ONE
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3662806/?tool=EBI

Similar Items

Correction: The Pathogenic Aβ43 Is Enriched in Familial and Sporadic Alzheimer Disease
Published: (2013-01-01)

Correction: The Pathogenic Aβ43 Is Enriched in Familial and Sporadic Alzheimer Disease.
by: Anna Sandebring, et al.
Published: (2013-01-01)

Correction: The Pathogenic Aβ43 Is Enriched in Familial and Sporadic Alzheimer Disease.
by: Anna Sandebring, et al.
Published: (2013-01-01)

The pathogenic aβ43 is enriched in familial and sporadic Alzheimer disease.
by: Anna Sandebring, et al.
Published: (2013-01-01)

Amyloid β Modification: A Key to the Sporadic Alzheimer's Disease?
by: Evgeny P. Barykin, et al.
Published: (2017-05-01)

Switched Aβ43 generation in familial Alzheimer’s disease with presenilin 1 mutation
by: Nobuto Kakuda, et al.
Published: (2021-11-01)

TDP-43 pathological changes in early onset familial and sporadic Alzheimer's disease, late onset Alzheimer's disease and Down's syndrome: association with age, hippocampal sclerosis and clinical phenotype.
by: Davidson, Y, et al.
Published: (2011)

BIN1 is decreased in sporadic but not familial Alzheimer's disease or in aging.
by: Elizabeth B C Glennon, et al.
Published: (2013-01-01)

Epistasis in sporadic Alzheimer's disease.
by: Combarros, O, et al.
Published: (2009)

Amyloid-β Oligomers Unveil a Novel Primate Model of Sporadic Alzheimer’s Disease
by: Joseph eJebelli, et al.
Published: (2015-03-01)

Influence of Coding Variability in APP-Aβ Metabolism Genes in Sporadic Alzheimer's Disease.
by: Celeste Sassi, et al.
Published: (2016-01-01)

PATHOGENIC POTENTIAL OF TDP-43 PROTEINOPATHY IN A MICE MODEL OF ALZHEIMER'S DISEASE
by: Laura Garcia Toscano, et al.
Published: (2023-10-01)

Neuroanatomy and Pathology of Sporadic Alzheimer's Disease /
by: Braak, Heiko, 1937- author., et al.
Published: (2015)

The relevance of cerebrospinal fluid α-synuclein levels to sporadic and familial Alzheimer’s disease
by: Daniel Twohig, et al.
Published: (2018-11-01)

Phosphorylated TDP-43 (pTDP-43) aggregates in the axial skeletal muscle of patients with sporadic and familial amyotrophic lateral sclerosis
by: Matthew D. Cykowski, et al.
Published: (2018-04-01)

N-truncated Aβ4–x peptides in sporadic Alzheimer’s disease cases and transgenic Alzheimer mouse models
by: Oliver Wirths, et al.
Published: (2017-10-01)

Distinct cerebrospinal fluid amyloid β peptide signatures in sporadic and <it>PSEN1 </it>A431E-associated familial Alzheimer's disease
by: Galasko Douglas, et al.
Published: (2010-01-01)

Transcriptomic profiling of sporadic Alzheimer’s disease patients
by: Andrew B. Caldwell, et al.
Published: (2022-10-01)

Aβ38 and Aβ43 do not differentiate between Alzheimer's disease and cerebral amyloid angiopathy
by: Justina Dargvainiene, et al.
Published: (2024-03-01)

TDP-43 Pathology in Alzheimer’s Disease
by: Axel Meneses, et al.
Published: (2021-12-01)

Can mouse models mimic sporadic Alzheimer’s disease?
by: Bettina M Foidl, et al.
Published: (2020-01-01)

Correction: Glycoform-Selective Prion Formation in Sporadic and Familial Forms of Prion Disease
Published: (2013-01-01)

Correction: Glycoform-Selective Prion Formation in Sporadic and Familial Forms of Prion Disease.
by: Xiangzhu Xiao, et al.
Published: (2013-01-01)

A Comprehensive Machine Learning Framework for the Exact Prediction of the Age of Onset in Familial and Sporadic Alzheimer’s Disease
by: Jorge I. Vélez, et al.
Published: (2021-05-01)

Functional gradients of the medial parietal cortex in a healthy cohort with family history of sporadic Alzheimer’s disease
by: Dániel Veréb, et al.
Published: (2023-04-01)

TDP-43 interacts with amyloid-β, inhibits fibrillization, and worsens pathology in a model of Alzheimer’s disease
by: Shih, Y-H, et al.
Published: (2020)

TDP-43 interacts with amyloid-β, inhibits fibrillization, and worsens pathology in a model of Alzheimer’s disease
by: Yao-Hsiang Shih, et al.
Published: (2020-11-01)

Curcumin Attenuated Neurotoxicity in Sporadic Animal Model of Alzheimer’s Disease
by: Ines ELBini-Dhouib, et al.
Published: (2021-05-01)

The Role of BMI1 in Late-Onset Sporadic Alzheimer’s Disease
by: Ryan Hogan, et al.
Published: (2020-07-01)

Repurposing verapamil for prevention of cognitive decline in sporadic Alzheimer’s disease
by: Heba A Ahmed, et al.
Published: (2022-01-01)

Olfactory Dysfunction in Familial and Sporadic Parkinson's Disease
by: Bruce A. Chase, et al.
Published: (2020-05-01)

Melatonin reduces β-amyloid accumulation and improves short-term memory in streptozotocin-induced sporadic Alzheimer’s disease model
by: Marcos K. Andrade, et al.
Published: (2023-06-01)

Author Correction: Peripheral inflammatory immune response differs among sporadic and familial Parkinson’s disease
by: Laura Muñoz-Delgado, et al.
Published: (2023-02-01)

TDP-43: From Alzheimer’s Disease to Limbic-Predominant Age-Related TDP-43 Encephalopathy
by: Wendi Huang, et al.
Published: (2020-02-01)

Mechanisms of Pathogenic Tau and Aβ Protein Spreading in Alzheimer’s Disease
by: Paolo d‘Errico, et al.
Published: (2020-08-01)

Mitochondrial Bioenergetics Is Altered in Fibroblasts from Patients with Sporadic Alzheimer's Disease
by: María J. Pérez, et al.
Published: (2017-10-01)

The relationship of soluble TREM2 to other biomarkers of sporadic Alzheimer’s disease
by: So-Hee Park, et al.
Published: (2021-06-01)

Sporadic Burkitt lymphomas of children and adolescents in Chinese: a clinicopathological study of 43 cases
by: Bi Cheng-Feng, et al.
Published: (2012-06-01)

The Shortening of Leukocyte Telomere Length Contributes to Alzheimer’s Disease: Further Evidence from Late-Onset Familial and Sporadic Cases
by: Paolina Crocco, et al.
Published: (2023-09-01)

Differential Profile of Systemic Extracellular Vesicles From Sporadic and Familial Alzheimer’s Disease Leads to Neuroglial and Endothelial Cell Degeneration
by: Juan Villar-Vesga, et al.
Published: (2020-11-01)